Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Specialty pharmaceutical company, Depomed has launched Gralise (gabapentin) tablets as a once-daily treatment for postherpetic neuralgia (PHN).
Subscribe to our email newsletter
Postherpetic neuralgia (PHN) is referred to the pain following healing of the rash associated with shingles.
Gralise is available as a prescription drug in a 30-day starter pack, which allows titration of the drug to full dose in 15 days, as well as bottles of 600 mg and 300 mg tablets.
The drug is a formulation of gabapentin made using polymer technology which helps in gradual release of the drug.